CONFLICT OF INTEREST
All authors received Patient‐Centered Outcomes Research Institute (PCORI) research funding through their institution. Dr. Sheng has received Pfizer research funding through her institution. Dr. Snyder has received personal royalties for section authorship in up‐to‐date, personal consulting fees from Janssen (via Health Outcomes Solutions), and research funding from Genentech and Pfizer through her institution. Dr. Johnston has received NIH grant 1R01CA252101‐01A1. Dr. Joyner serves as a non‐paid board member for the National Board for Respiratory Care, Salisbury University Alumni, and Salisbury University College of Health and Human Sciences. Dr. Tran received research funding from Astellas Pharm, Bayer Healthcare, and RefleXion Medial Inc; personal fees from Consulting from RefleXion, Janssen‐Taris Biomedical, Myovant and AstraZeneca outside the submitted work; and has a patent 9,114,158 ‐ Compounds and Methods of Use in Ablative Radiotherapy licensed to Natsar Pharm. Dr. Peairs and Dr. Choi have received research funding from a Merck Foundation Grant through their institution.